Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Recombinant Soluble Respiratory Syncytial Virus F Protein That Lacks Heptad Repeat B, Contains a GCN4 Trimerization Motif and Is Not Cleaved Displays Prefusion-Like Characteristics.

Widjaja I, Rigter A, Jacobino S, van Kuppeveld FJ, Leenhouts K, Palomo C, Melero JA, Leusen JH, Haijema BJ, Rottier PJ, de Haan CA.

PLoS One. 2015 Jun 24;10(6):e0130829. doi: 10.1371/journal.pone.0130829. eCollection 2015.

2.

Hemagglutinin receptor specificity and structural analyses of respiratory droplet-transmissible H5N1 viruses.

de Vries RP, Zhu X, McBride R, Rigter A, Hanson A, Zhong G, Hatta M, Xu R, Yu W, Kawaoka Y, de Haan CA, Wilson IA, Paulson JC.

J Virol. 2014 Jan;88(1):768-73. doi: 10.1128/JVI.02690-13. Epub 2013 Oct 30.

3.

A protective and safe intranasal RSV vaccine based on a recombinant prefusion-like form of the F protein bound to bacterium-like particles.

Rigter A, Widjaja I, Versantvoort H, Coenjaerts FE, van Roosmalen M, Leenhouts K, Rottier PJ, Haijema BJ, de Haan CA.

PLoS One. 2013 Aug 12;8(8):e71072. doi: 10.1371/journal.pone.0071072. eCollection 2013.

4.

Protective efficacy of Newcastle disease virus expressing soluble trimeric hemagglutinin against highly pathogenic H5N1 influenza in chickens and mice.

Cornelissen LA, de Leeuw OS, Tacken MG, Klos HC, de Vries RP, de Boer-Luijtze EA, van Zoelen-Bos DJ, Rigter A, Rottier PJ, Moormann RJ, de Haan CA.

PLoS One. 2012;7(8):e44447. doi: 10.1371/journal.pone.0044447. Epub 2012 Aug 28.

5.

Glycan-dependent immunogenicity of recombinant soluble trimeric hemagglutinin.

de Vries RP, Smit CH, de Bruin E, Rigter A, de Vries E, Cornelissen LA, Eggink D, Chung NP, Moore JP, Sanders RW, Hokke CH, Koopmans M, Rottier PJ, de Haan CA.

J Virol. 2012 Nov;86(21):11735-44. doi: 10.1128/JVI.01084-12. Epub 2012 Aug 22.

6.

Prion protein self-interaction in prion disease therapy approaches.

Rigter A, Priem J, Langeveld JP, Bossers A.

Vet Q. 2011 Sep;31(3):115-28. doi: 10.1080/01652176.2011.604976. Review.

PMID:
22029882
7.

Only two residues are responsible for the dramatic difference in receptor binding between swine and new pandemic H1 hemagglutinin.

de Vries RP, de Vries E, Moore KS, Rigter A, Rottier PJ, de Haan CA.

J Biol Chem. 2011 Feb 18;286(7):5868-75. doi: 10.1074/jbc.M110.193557. Epub 2010 Dec 20.

8.

Prion protein self-interactions: a gateway to novel therapeutic strategies?

Rigter A, Langeveld JP, van Zijderveld FG, Bossers A.

Vaccine. 2010 Nov 16;28(49):7810-23. doi: 10.1016/j.vaccine.2010.09.012. Epub 2010 Oct 20. Review.

PMID:
20932496
9.

A single immunization with soluble recombinant trimeric hemagglutinin protects chickens against highly pathogenic avian influenza virus H5N1.

Cornelissen LA, de Vries RP, de Boer-Luijtze EA, Rigter A, Rottier PJ, de Haan CA.

PLoS One. 2010 May 14;5(5):e10645. doi: 10.1371/journal.pone.0010645.

10.

Prion protein self-peptides modulate prion interactions and conversion.

Rigter A, Priem J, Timmers-Parohi D, Langeveld JP, van Zijderveld FG, Bossers A.

BMC Biochem. 2009 Nov 30;10:29. doi: 10.1186/1471-2091-10-29.

11.

Mapping functional prion-prion protein interaction sites using prion protein based peptide-arrays.

Rigter A, Priem J, Timmers-Parohi D, Langeveld JP, Bossers A.

Methods Mol Biol. 2009;570:257-71. doi: 10.1007/978-1-60327-394-7_12. Review.

PMID:
19649598
12.

Mapping of possible prion protein self-interaction domains using peptide arrays.

Rigter A, Langeveld JP, Timmers-Parohi D, Jacobs JG, Moonen PL, Bossers A.

BMC Biochem. 2007 Apr 12;8:6.

13.
14.

In vitro conversion of normal prion protein into pathologic isoforms.

Bossers A, Rigter A, de Vries R, Smits MA.

Clin Lab Med. 2003 Mar;23(1):227-47. Review.

PMID:
12733434
15.

Homonucleotide stretches in chromosomal DNA of Campylobacter jejuni display high frequency polymorphism as detected by direct PCR analysis.

Wassenaar TM, Wagenaar JA, Rigter A, Fearnley C, Newell DG, Duim B.

FEMS Microbiol Lett. 2002 Jun 18;212(1):77-85.

16.

Differentiation of Campylobacter species by AFLP fingerprinting.

Duim B, Vandamme PAR, Rigter A, Laevens S, Dijkstra JR, Wagenaar JA.

Microbiology. 2001 Oct;147(Pt 10):2729-2737. doi: 10.1099/00221287-147-10-2729.

PMID:
11577152
17.

Neonatal sepsis by Campylobacter jejuni: genetically proven transmission from a household puppy.

Wolfs TF, Duim B, Geelen SP, Rigter A, Thomson-Carter F, Fleer A, Wagenaar JA.

Clin Infect Dis. 2001 Mar 1;32(5):E97-9. Epub 2001 Feb 23.

PMID:
11229867
18.
19.

Molecular characterization of Campylobacter jejuni from patients with Guillain-Barré and Miller Fisher syndromes.

Endtz HP, Ang CW, van Den Braak N, Duim B, Rigter A, Price LJ, Woodward DL, Rodgers FG, Johnson WM, Wagenaar JA, Jacobs BC, Verbrugh HA, van Belkum A.

J Clin Microbiol. 2000 Jun;38(6):2297-301.

20.

Computer-assisted analysis and epidemiological value of genotyping methods for Campylobacter jejuni and Campylobacter coli.

de Boer P, Duim B, Rigter A, van Der Plas J, Jacobs-Reitsma WF, Wagenaar JA.

J Clin Microbiol. 2000 May;38(5):1940-6.

21.

Supplemental Content

Loading ...
Support Center